Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Net Income: 2016-2024

Historic Net Income for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to -$9.9 million.

  • Organogenesis Holdings' Net Income rose 74.90% to $21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.7 million, marking a year-over-year decrease of 31.63%. This contributed to the annual value of -$9.9 million for FY2024, which is 299.35% down from last year.
  • According to the latest figures from FY2024, Organogenesis Holdings' Net Income is -$9.9 million, which was down 299.35% from $4.9 million recorded in FY2023.
  • In the past 5 years, Organogenesis Holdings' Net Income registered a high of $94.2 million during FY2021, and its lowest value of -$9.9 million during FY2024.
  • Moreover, its 3-year median value for Net Income was $4.9 million (2023), whereas its average is $3.5 million.
  • In the last 5 years, Organogenesis Holdings' Net Income soared by 446.61% in 2021 and then tumbled by 299.35% in 2024.
  • Over the past 5 years, Organogenesis Holdings' Net Income (Yearly) stood at $17.2 million in 2020, then skyrocketed by 446.61% to $94.2 million in 2021, then crashed by 83.51% to $15.5 million in 2022, then plummeted by 68.16% to $4.9 million in 2023, then slumped by 299.35% to -$9.9 million in 2024.